Compare DFTX & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DFTX | PSN |
|---|---|---|
| Founded | N/A | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.2B |
| IPO Year | 2020 | 2019 |
| Metric | DFTX | PSN |
|---|---|---|
| Price | $30.21 | $49.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | ★ $72.83 | $61.36 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.77 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $6,364,245,000.00 |
| Revenue This Year | N/A | $0.14 |
| Revenue Next Year | N/A | $4.75 |
| P/E Ratio | ★ N/A | $58.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.62 | $36.26 |
| 52 Week High | $49.70 | $86.70 |
| Indicator | DFTX | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 53.43 |
| Support Level | $20.43 | $49.38 |
| Resistance Level | $38.59 | $53.25 |
| Average True Range (ATR) | 2.10 | 2.24 |
| MACD | -0.21 | -0.27 |
| Stochastic Oscillator | 3.34 | 37.87 |
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.